We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGRE
651
DELISTED
Paramount Group
PGRE
$296K 0.04%
+18,584
New +$297K
LCUT icon
652
Lifetime Brands
LCUT
$202M
$294K 0.04%
+19,531
New +$241K
UBA
653
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$294K 0.04%
14,040
-53,905
-79% -$1.07M
GBNK
654
DELISTED
Guaranty Bancorp
GBNK
$292K 0.04%
+18,859
New +$291K
GLQ
655
Clough Global Equity Fund
GLQ
$153M
$291K 0.04%
+26,710
New +$289K
PETX
656
DELISTED
Aratana Therapeutics, Inc.
PETX
$290K 0.04%
52,518
-19,748
-27% -$74.2K
CABO icon
657
Cable One
CABO
$224M
$289K 0.04%
+660
New +$281K
NGHC
658
DELISTED
National General Holdings Corp
NGHC
$289K 0.04%
+13,382
New +$270K
PRA
659
DELISTED
ProAssurance
PRA
$288K 0.04%
+5,690
New +$281K
SUPN icon
660
Supernus Pharmaceuticals
SUPN
$2.73B
$288K 0.04%
+18,871
New +$246K
CORR
661
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$288K 0.04%
+14,322
New +$216K
OCSI
662
DELISTED
Oaktree Strategic Income Corporation
OCSI
$287K 0.04%
+36,131
New +$272K
NTK
663
DELISTED
NORTEK INC COM NEW (DE)
NTK
$285K 0.04%
5,895
-61,760
-91% -$2.52M
SRCE icon
664
1st Source
SRCE
$2.09B
$284K 0.04%
+8,906
New +$271K
OTIC
665
DELISTED
Otonomy, Inc.
OTIC
$284K 0.04%
+19,018
New +$299K
EOD
666
Allspring Global Dividend Opportunity Fund
EOD
$276M
$283K 0.04%
+47,334
New +$267K
VC icon
667
Visteon
VC
$2.82B
$283K 0.04%
+3,552
New +$280K
ACOR
668
DELISTED
Acorda Therapeutics
ACOR
$282K 0.04%
+89
New +$369K
NMA
669
DELISTED
NUVEEN MUNI ADVANTAGE FUND
NMA
$282K 0.04%
+19,629
New +$277K
ARTNA icon
670
Artesian Resources
ARTNA
$355M
$281K 0.04%
+10,049
New +$280K
CHRS icon
671
Coherus Oncology
CHRS
$225M
$280K 0.04%
+13,167
New +$216K
ET icon
672
Energy Transfer Partners
ET
$68.5B
$279K 0.04%
+39,125
New +$307K
RVT icon
673
Royce Value Trust
RVT
$2.21B
$279K 0.04%
+23,865
New +$257K
SNDA icon
674
Sonida Senior Living
SNDA
$2.03B
$279K 0.04%
+1,005
New +$262K
TNET icon
675
TriNet
TNET
$2.94B
$277K 0.04%
+19,331
New +$274K
25 26
27
28 29

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.